While chemotherapy and radiation primarily target highly proliferating cancer cells, ADT and ARSI aim to restrict PCa cells, whose proliferation is dependent on signaling by the androgen receptor (AR), an androgen-responsive transcription factor. Here, AR is linked to cancer.